Quarterly report pursuant to Section 13 or 15(d)

Note 21 - Segment Information: Schedule of Segment Information (Tables)

v3.20.1
Note 21 - Segment Information: Schedule of Segment Information (Tables)
3 Months Ended
Mar. 31, 2020
Tables/Schedules  
Schedule of Segment Information

 

 

 

Cannabis and

Medical

Marijuana

Segment

 

Facility

Operations

Related

 

Corporate

and

Eliminations

 

Consolidated

Three months ended March 31, 2020

 

 

 

 

 

 

 

 

Net revenue

$

12,538

$

1,136,924

$

-

$

1,149,462

Operating income (loss)

 

(8,905)

 

34,176

 

(261,994)

 

(236,723)

Interest income

 

980

 

-

 

18,423

 

19,403

Interest expense

 

-

 

8,471

 

(1,134))

 

7,337

Property additions

 

-

 

3,329

 

-

 

3,329

Depreciation and amortization

 

-

 

2,640

 

1,202

 

3,842

 

 

 

 

 

 

 

 

 

Three months ended March 31, 2019

 

 

 

 

 

 

 

 

Net revenue

$

120,089

$

955,906

$

-

$

1,075,995

Operating income (loss)

 

(606,697)

 

17,179

 

(266,726)

 

(856,244)

Interest income

 

20,679

 

3

 

21,898

 

42,580

Interest expense

 

-

 

5,657

 

(1,134)

 

4,523

Property additions

 

-

 

8,159

 

-

 

8,159

Depreciation and amortization

 

-

 

2,653

 

2,932

 

5,585